Psychemedics Corp (PMD)

2.63 +0.07 (+2.73%) USD  |  NASDAQ  |  Apr 19, 15:49
More

Psychemedics Research and Development Expense (Quarterly): 0.285M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
December 31, 2023 0.285M
September 30, 2023 0.275M
June 30, 2023 0.286M
March 31, 2023 0.298M
December 31, 2022 0.323M
September 30, 2022 0.328M
June 30, 2022 0.357M
March 31, 2022 0.318M
December 31, 2021 0.313M
September 30, 2021 0.244M
June 30, 2021 0.293M
March 31, 2021 0.28M
December 31, 2020 0.299M
September 30, 2020 0.305M
June 30, 2020 0.345M
March 31, 2020 0.331M
December 31, 2019 0.354M
September 30, 2019 0.393M
June 30, 2019 0.40M
March 31, 2019 0.42M
December 31, 2018 0.462M
September 30, 2018 0.372M
June 30, 2018 0.358M
March 31, 2018 0.359M
December 31, 2017 0.352M
Date Value
September 30, 2017 0.353M
June 30, 2017 0.321M
March 31, 2017 0.33M
December 31, 2016 0.356M
September 30, 2016 0.348M
June 30, 2016 0.35M
March 31, 2016 0.36M
December 31, 2015 0.3471M
September 30, 2015 0.392M
June 30, 2015 0.4371M
March 31, 2015 0.4558M
December 31, 2014 0.3618M
September 30, 2014 0.3638M
June 30, 2014 0.2774M
March 31, 2014 0.345M
December 31, 2013 0.2671M
September 30, 2013 0.2033M
June 30, 2013 0.19M
March 31, 2013 0.1647M
December 31, 2012 0.1465M
September 30, 2012 0.2971M
June 30, 2012 0.2139M
March 31, 2012 0.168M
December 31, 2011 0.2076M
September 30, 2011 0.1363M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.244M
Minimum
Sep 2021
0.40M
Maximum
Jun 2019
0.3172M
Average
0.313M
Median
Dec 2021

Research and Development Expense (Quarterly) Benchmarks

Delcath Systems Inc 4.709M
Star Equity Holdings Inc --
Exact Sciences Corp 114.92M
CytoSorbents Corp 4.096M
Progyny Inc --